Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

Clinical trial NCT00634049 · COMPLETED

Trial details

NCT number: NCT00634049
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Aspergillosis Invasive Fungal Infections

Start date: 2008-04-22
Primary completion: 2014-01-03
Enrollment: 149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.